These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Physiology and pharmacology of extrapyramidal tract]. Yoshida M, Mizuno Y. Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646 [No Abstract] [Full Text] [Related]
5. The effects of acetylcholine and dopamine on the caudate nucleus depleted of biogenic amines. Spehlmann R. Brain; 1975 Jun; 98(2):219-30. PubMed ID: 1148816 [Abstract] [Full Text] [Related]
6. [Stereotyped behavior and the nigro-strio-nigral system]. Arushanian EB. Zh Vyssh Nerv Deiat Im I P Pavlova; 1985 Jun; 35(5):819-32. PubMed ID: 2866641 [No Abstract] [Full Text] [Related]
7. In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat. Besson MJ, Kemel ML, Gauchy C, Girault JA, Spampinato U, Lantin N, Desban M, Glowinski J. Ann N Y Acad Sci; 1986 Jun; 473():475-88. PubMed ID: 3541740 [No Abstract] [Full Text] [Related]
8. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei. Wolfarth S. Pol J Pharmacol Pharm; 1976 Jun; 28(5):469-93. PubMed ID: 796834 [No Abstract] [Full Text] [Related]
9. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway. Krueger BK, Forn J, Walters JR, Roth RH, Greengard P. Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096 [No Abstract] [Full Text] [Related]
11. The dopaminergic nigrostriatal system: development, physiology, disease. von Bohlen Und Halbach O, Krieglstein K, Schober A, Schulz JB. Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830 [No Abstract] [Full Text] [Related]
12. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity. Feltz P. Appl Neurophysiol; 1979 Oct; 42(1-2):47-50. PubMed ID: 222207 [No Abstract] [Full Text] [Related]
18. Locomotor activity and speed of movements in relation to monoamine-acting drugs. Hassler R, Wagner A. Int J Neurol; 1975 Mar; 10(1-4):80-97. PubMed ID: 126971 [No Abstract] [Full Text] [Related]